Metrics as of 10/15/2026, 11:34 PM (Berlin time), refresh in progress.
Creo Medical Stock
Creo Medical Limited
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United Kingdom
- CEO
- Craig Jonathan Gulliford
- Employees
- 104
- Market cap
- £48 M
- IPO
- 09/12/2016
Creo Medical Limited, a UK-based enterprise and subsidiary of Creo Medical Group plc, specializes in the innovation and creation of electrosurgical medical devices for surgical endoscopy applications. Founded in 2003 as MicroOncology Ltd and headquartered in Chepstow, the company's core offering is Croma, an advanced…
Creo Medical stock: price history
1D
+1.2%
1W
+0.0%
1M
-15.2%
6M
-19.2%
YTD
+6.1%
1Y
-6.7%
2Y
-49.4%
5Y
-93.8%
10Y
–
Next earnings date
Next earnings date
02/06/2027 (in 228 days)
Volatility around earnings
~33% stronger price swings than usual
Ask the agents about Creo Medical
Creo Medical stock metrics
P/E
-2.28
P/B
0.9
EV/EBITDA
-2.41
RETURN ON EQUITY
-14.9%
NET MARGIN
-225.0%
DEBT/EQUITY
0.08
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
92.4%
FLOAT SHARES
414,991,437
AVG. DAILY VOLUME (30D)
896,779
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Creo Medical stock
What does Creo Medical do?
Creo Medical Limited is a company in the Healthcare sector, Medical - Devices industry, headquartered in United Kingdom.
The CEO is Craig Jonathan Gulliford, the company employs around 104 people.
The IPO was on 09/12/2016; the stock trades on LSE under the ticker CREO.L.
When does Creo Medical report next?
The next earnings date is 02/06/2027.
Around past earnings, price swings were roughly 33% stronger than usual.
Does Creo Medical pay a dividend?
No, Creo Medical currently does not pay a dividend.
Which stocks are comparable to Creo Medical?
Comparable stocks include Smith & Nephew, LivaNova, Abbott Laboratories, Medtronic, Stryker, Boston Scientific, Edwards Lifesciences and Siemens Healthineers.
How can I get Creo Medical stock analyzed?
Clicking "Analyze stock" lets five strategies assess Creo Medical against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.